Worldwide emergence of carbapenem-resistant Acinetobacter spp.
暂无分享，去创建一个
[1] M. Kaufmann,et al. Acinetobacter spp. isolates with reduced susceptibilities to carbapenems in a UK burns unit. , 1998, The Journal of antimicrobial chemotherapy.
[2] K. Bush,et al. Carbapenem-hydrolyzing beta-lactamases , 1997, Antimicrobial agents and chemotherapy.
[3] E Bergogne-Bérézin,et al. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features , 1996, Clinical microbiology reviews.
[4] C. Urban,et al. Interaction of sulbactam, clavulanic acid and tazobactam with penicillin-binding proteins of imipenem-resistant and -susceptible acinetobacter baumannii , 1995 .
[5] P. Tilley,et al. Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] S. Amyes,et al. ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii , 1993 .
[7] P. Turner,et al. In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I , 1989, Antimicrobial Agents and Chemotherapy.
[8] A. Harris,et al. The use of analytical isoelectric focusing for detection and identification of beta-lactamases. , 1975, Journal of general microbiology.